Unbiased AI-powered news
5 stories related to this topic, newest first.
thegatewaypundit.comCalifornia’s attorney general filed suit against the genetic testing company, alleging inadequate security allowed a 2023 breach that exposed data of nearly 7 million users. The complaint seeks civil penalties and orders barring further violations of state privacy law.
newser.comRob Bonta filed suit Thursday in San Francisco Superior Court against the company formerly known as 23andMe, alleging it failed to protect customer data and misled users about the breach.
cointelegraph.comAnne Wojcicki bought the genetic testing company after it faced near-loss. The firm now operates as a nonprofit. A STAT interview discusses changes and continuity.
sciencenews.orgResearchers have identified that genomic and demographic data can predict the magnitude of weight loss from GLP-1 drugs. This approach involves analysis by 23andMe. The findings focus on drug response and side effects in obesity treatment.
sciencenews.orgA study published in Nature identifies variations in two genes associated with greater weight loss and increased side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to nearly 28,000 23andMe users, shows modest genetic i…